Adenomyosis, strictly speaking, cannot recur after a total hysterectomy because the uterus itself is gone and adenomyosis is defined as endometrial-like tissue growing within the uterine muscle wall. However, that neat answer obscures several real scenarios that bring people to this question in the first place: persistent pelvic pain after surgery, rare adenomyotic tissue found outside the uterus, and complications related to how the uterus was removed. Understanding these distinctions matters, because “the adenomyosis is gone but I still have symptoms” is a surprisingly common experience that deserves a more complete explanation than a simple no.
Why Hysterectomy Is Considered the Definitive Treatment
Adenomyosis lives in the muscular wall of the uterus. When the entire uterus is removed, the tissue where adenomyosis grows is removed with it. That is why hysterectomy has long been viewed as the one treatment that eliminates adenomyosis rather than just managing it. A trial comparing hysterectomy with uterine artery embolization for symptomatic adenomyosis found that roughly 95 percent of women who underwent hysterectomy were satisfied with the outcome after one year, and both pain and quality-of-life scores improved significantly.1PubMed Central. Quality of life 1 year after uterine artery embolization vs hysterectomy for symptomatic adenomyosis (QUESTA study) Hysterectomy produced a greater improvement in pain scores than embolization did, which reflects the fact that removing the entire organ addresses the disease at its source.
For comparison, conservative surgeries that try to cut out adenomyotic tissue while preserving the uterus carry substantial recurrence rates. One retrospective study of 133 patients who had conservative surgery found that about 39 percent experienced recurrence over an average follow-up of just over four years.2BMC Women’s Health. Recurrence rates and associated risk factors after conservative surgery for adenomyosis: a retrospective study The recurrence risk was higher in women who had multiple adenomyotic lesions, disease involving the back wall of the uterus, or co-existing endometriosis. Hysterectomy avoids that recurrence problem entirely, at the obvious cost of losing the uterus.
Persistent Pain After Hysterectomy
The most common reason people ask whether adenomyosis can “come back” is that they still have pelvic pain after surgery. Persistent pain after hysterectomy for chronic pelvic pain is a recognized phenomenon, but the cause is usually not adenomyosis itself. A study examining predictors of persistent pelvic pain following hysterectomy found that finding adenomyosis on the pathology report was not associated with ongoing pain.3PubMed Central. Incidence and predictors of persistent pelvic pain following hysterectomy in women with chronic pelvic pain What was linked to persistent pain included findings of endometriosis and uterine fibroids at the time of surgery.
This matters because adenomyosis and endometriosis frequently coexist. In studies of conservative adenomyosis surgery, women who also had endometriosis experienced much higher recurrence of symptoms. One long-term study found that recurrence rates in patients with co-existing endometriosis were roughly three to five times higher than in those without it, regardless of the surgical approach used.4Journal of Pain Research. Comparisons of the efficacy and recurrence of adenomyomectomy for severe uterine diffuse adenomyosis via laparotomy versus laparoscopy: a long-term result in a single institution After hysterectomy, the adenomyosis is gone, but endometriosis implants on the bowel, bladder, pelvic sidewall, or other structures remain untouched unless the surgeon specifically addressed them. For many women experiencing persistent pain post-hysterectomy, endometriosis rather than adenomyosis is the culprit.
Other contributors to ongoing pain include pelvic floor dysfunction, adhesions from the surgery itself, central sensitization (where the nervous system continues generating pain signals even after the original source is removed), and musculoskeletal issues that may have been present all along but were attributed to the uterus. None of these represent adenomyosis returning. They represent other conditions that were either missed, undertreated, or developed independently.
Extrauterine Adenomyomas
There is one genuine scenario in which adenomyosis-like tissue can be found after a hysterectomy, and it is rare. Extrauterine adenomyomas are masses of endometrial glands and smooth muscle that develop outside the uterus entirely. A literature review identified only 34 reported cases, with the most common locations being the pararectal space, the ovary, and the broad ligament.5PubMed. Extrauterine adenomyoma: a review of the literature Other reported sites included the round ligament, areas near the ovary, the pelvic wall, and even extrapelvic locations like the liver, appendix, and small bowel.
These lesions are not recurrences in the traditional sense. They may represent displaced remnants of the tissue that forms the reproductive tract during embryonic development, or they may arise through a process where normal tissue transforms into endometrial-like tissue in an abnormal location. The mechanisms proposed for how adenomyosis develops in the uterus itself, including metaplasia of displaced embryonic tissue and differentiation of stem cells, could also explain how similar tissue occasionally appears elsewhere.6PubMed Central. Pathogenesis of Human Adenomyosis: Current Understanding and Its Association with Infertility
Distinguishing an extrauterine adenomyoma from endometriosis can be tricky, even under a microscope. Both conditions involve endometrial-like glands outside their normal location. The key difference is that adenomyomas have a prominent smooth muscle component arranged in a pattern resembling a uterine tumor, rather than the scattered glands and surrounding inflammatory tissue more typical of endometriosis.7International Journal of Gynecological Pathology. Extrauterine Adenomyoma With Atypical (Symplastic) Smooth Muscle Cells Some of these lesions share features with so-called “uterus-like mass” lesions that have been recorded in various sites including the broad ligament, ovary, and small bowel. For the patient, the clinical distinction may be academic. The point is that the mass exists, it can cause symptoms, and removing it surgically is usually the treatment.
The Morcellation Problem
One specific situation that can lead to adenomyosis-like tissue appearing after hysterectomy involves morcellation, a technique sometimes used during laparoscopic surgery to break the uterus into smaller pieces so it can be removed through small incisions. If adenomyotic tissue is fragmented and a piece is inadvertently left behind in the pelvic or abdominal cavity, it can implant and grow into a new mass.
A case report documented an extrauterine adenomyoma presenting two years after a laparoscopic hysterectomy that used morcellation.8PubMed Central. Late presentation of extrauterine adenomyomas after laparoscopic morcellation at hysterectomy: a case report The tissue essentially seeded itself in a new location during the original procedure. This is not adenomyosis “coming back” in the biological sense of the disease recurring on its own. It is a complication of how the surgery was performed, resulting in tissue being left behind that then continued to behave the way adenomyotic tissue does.
Concerns about morcellation have grown over the past decade, partly because of the risk of spreading undetected malignant tissue but also because of cases like this. Contained morcellation, where the tissue is broken up inside a bag to prevent fragments from scattering, has become more common as a result. If you had a laparoscopic hysterectomy with morcellation and develop a new pelvic mass or recurrent symptoms years later, the possibility of implanted adenomyotic tissue is worth discussing with your doctor, even though it remains uncommon.
Does It Matter Whether the Cervix Was Kept?
Some women undergo a supracervical (subtotal) hysterectomy, which removes the body of the uterus but leaves the cervix in place. Because a small amount of uterine tissue can remain at the junction between the cervix and the uterine body, it is reasonable to wonder whether adenomyosis could persist or recur there.
The available evidence suggests it does not make a meaningful difference. A study comparing symptom persistence in women with pathologically confirmed adenomyosis found no difference between total and supracervical hysterectomy. Retaining the cervix did not appear to increase the risk of ongoing symptoms or reduce patient satisfaction.9PubMed. Persistence of Symptoms After Total vs Supracervical Hysterectomy in Women with Histopathological Diagnosis of Adenomyosis This is reassuring for women who chose or were offered a supracervical approach, which some surgeons prefer because it can have a shorter recovery and a lower risk of certain complications. While isolated case reports of cervical stump adenomyosis exist, the overall research does not support routine total hysterectomy over supracervical hysterectomy solely to prevent adenomyosis recurrence.
Does Keeping the Ovaries Affect the Risk?
Adenomyosis is an estrogen-dependent condition, which naturally raises the question of whether leaving the ovaries in place at the time of hysterectomy could fuel residual or recurrent disease. If adenomyotic tissue were left behind, whether from morcellation, an extrauterine adenomyoma, or the small amount of tissue at the cervical stump, ongoing estrogen production could theoretically support its growth.
In practice, this concern has not been borne out in studies. A meta-analysis looking at predictors of persistent pain after hysterectomy for chronic pelvic pain found that ovarian conservation was not significantly associated with ongoing pain.10Obstetrics & Gynecology. Predictors of Persistent Pain After Hysterectomy for Chronic Pelvic Pain This is consistent with the broader understanding: once the uterus is removed, the main site of adenomyosis is gone, and ovarian hormones have little or no target tissue left to act on. Removing the ovaries to prevent adenomyosis recurrence would expose you to the health consequences of surgical menopause, including increased risks to bone density and cardiovascular health, without a demonstrated benefit for adenomyosis symptoms. Most gynecologists therefore recommend keeping the ovaries when possible, especially in younger women.
What Drives Recurrence After Conservative Surgery
Understanding what makes adenomyosis come back after uterus-sparing surgery helps put the hysterectomy question in perspective. In studies tracking women after conservative adenomyomectomy, several factors consistently predicted recurrence. Having two or more adenomyotic lesions, disease on the posterior uterine wall, and co-existing endometriosis all raised the recurrence risk substantially.2BMC Women’s Health. Recurrence rates and associated risk factors after conservative surgery for adenomyosis: a retrospective study
Postoperative hormonal treatment made a major difference. Women who received progestogen therapy after conservative surgery had dramatically lower recurrence rates, and similar benefits were seen with GnRH agonist treatment. A separate long-term study found that combining a GnRH agonist with a levonorgestrel-releasing intrauterine device or oral contraceptives after surgery reduced recurrence far more than using a GnRH agonist alone.4Journal of Pain Research. Comparisons of the efficacy and recurrence of adenomyomectomy for severe uterine diffuse adenomyosis via laparotomy versus laparoscopy: a long-term result in a single institution These findings are relevant to the hysterectomy conversation for two reasons. First, they highlight that adenomyosis is a stubborn disease that aggressively returns when any uterine tissue remains, underscoring why hysterectomy is so effective by comparison. Second, for women who had a hysterectomy but still have endometriosis or rare extrauterine adenomyotic tissue, hormonal management may still have a role in controlling residual symptoms.
When Hormonal Treatment Continues After Hysterectomy
In rare cases where extrauterine adenomyotic tissue is suspected or confirmed after a hysterectomy, medical treatment targeting estrogen may be used. GnRH agonists, which temporarily shut down ovarian hormone production, have been shown to shrink adenomyotic tissue. In one study of women with confirmed adenomyosis treated with an extended course of GnRH agonist with hormonal add-back therapy, uterine volume dropped significantly, from an average of about 295 cubic centimeters to roughly 184 cubic centimeters.11Biomedical and Pharmacology Journal. Extended GnRH Agonist and NETA Add-Back: An Effective and Safe Option for Refractory Endometriosis/Adenomyosis Pain While this study was conducted in women who still had their uterus, the principle that suppressing estrogen can shrink adenomyotic tissue applies to any location where that tissue exists. If a post-hysterectomy mass turns out to be an extrauterine adenomyoma, hormonal suppression could be tried before or instead of another surgery, particularly in women who prefer to avoid additional procedures.
Sorting Out Pain That Persists
If you have had a hysterectomy for adenomyosis and still experience pelvic pain, the most productive approach starts with not assuming the adenomyosis has come back. In the vast majority of cases, it has not. A structured evaluation should consider several possibilities:
- Endometriosis: If it was present before the hysterectomy and was not fully excised, it can continue causing pain on its own. This is probably the most common overlooked contributor.
- Adhesions: Scar tissue from surgery itself can tether organs together and cause pain with movement or bowel function.
- Pelvic floor dysfunction: Years of living with chronic pelvic pain can lead to muscle tension and nerve sensitization in the pelvic floor that persists even after the original pain source is gone.
- Central sensitization: The nervous system can become hypersensitive to pain signals after prolonged stimulation. This can perpetuate a chronic pain experience even when the tissue damage that originally caused it has been resolved.
- Extrauterine adenomyoma: Rare, but possible, especially if morcellation was used during the hysterectomy. Imaging can usually identify a discrete mass.
The takeaway from the research on persistent pain is that adenomyosis showing up on the pathology report after hysterectomy was not itself a predictor of ongoing pain.3PubMed Central. Incidence and predictors of persistent pelvic pain following hysterectomy in women with chronic pelvic pain That does not mean the pain is not real. It means the explanation usually lies elsewhere, and working with a specialist who considers the full range of possible causes is more likely to lead to relief than worrying specifically about adenomyosis recurrence.
How Adenomyosis Develops in the First Place
Part of the reason the “can it come back” question is so common is that the origins of adenomyosis are still not fully understood. The leading theory involves damage or disruption at the boundary between the inner lining of the uterus and the muscle wall beneath it, allowing endometrial cells to invade the muscle. But other proposed mechanisms include transformation of embryonic tissue remnants in abnormal locations, migration of endometrial stem cells into the muscle layer, and mutations in specific genes that alter how uterine cells behave.6PubMed Central. Pathogenesis of Human Adenomyosis: Current Understanding and Its Association with Infertility
The existence of multiple possible pathways helps explain why adenomyosis can occasionally show up in unusual places. If stem cells or embryonic remnants are involved, it is not entirely dependent on the uterus being present. That said, these alternative pathways seem to produce disease outside the uterus very rarely. The uterus remains overwhelmingly the site where adenomyosis occurs, and removing it overwhelmingly resolves the problem. The science of why adenomyosis develops at all is still catching up to the clinical reality that hysterectomy works well for most women, even if researchers cannot fully explain why the disease appeared in the first place.